TY - JOUR
T1 - Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
AU - Antonell, Anna
AU - Tort-Merino, Adria
AU - Rios, Jose
AU - Balasa, Mircea
AU - Borrego-Ecija, Sergi
AU - Auge, Josep M.
AU - Munoz-Garcia, Cristina
AU - Bosch, Beatriz
AU - Falgas, Neus
AU - Rami, Lorena
AU - Ramos-Campoy, Oscar
AU - Blennow, Kaj
AU - Zetterberg, Henrik
AU - Molinuevo, Jose L.
AU - Llado, Albert
AU - Sanchez-Valle, Raquel
N1 - ○2019theAlzheimer’sAssociation
PY - 2020/2
Y1 - 2020/2
N2 - Introduction: Synaptic damage, axonal neurodegeneration, and neuroinflammation are common features in Alzheimer's disease (AD), frontotemporal dementia (FTD), and Creutzfeldt-Jakob disease (CJD).Methods: Unicentric cohort of 353 participants included healthy control (HC) subjects, AD continuum stages, genetic AD and FTD, and FTD and CJD. We measured cerebrospinal fluid neurofilament light (NF-L), neurogranin (Ng), 14-3-3, and YKL-40 proteins.Results: Biomarkers showed differences in HC subjects versus AD, FTD, and CJD. Disease groups differed between them except AD versus FTD for YKL-40. Only NF-L differed between all stages within the AD continuum. AD and FTD symptomatic mutation carriers presented differences with respect to HC subjects. Applying the AT(N) system, 96% subjects were positive for neurodegeneration if 14-3-3 was used, 94% if NF-L was used, 62% if Ng was used, and 53% if YKL-40 was used.Discussion: Biomarkers of synapse and neurodegeneration differentiate HC subjects from neurodegenerative dementias and between AD, FTD, and CJD. NF-L and 14-3-3 performed similar to total tau when AT(N) system was applied.
AB - Introduction: Synaptic damage, axonal neurodegeneration, and neuroinflammation are common features in Alzheimer's disease (AD), frontotemporal dementia (FTD), and Creutzfeldt-Jakob disease (CJD).Methods: Unicentric cohort of 353 participants included healthy control (HC) subjects, AD continuum stages, genetic AD and FTD, and FTD and CJD. We measured cerebrospinal fluid neurofilament light (NF-L), neurogranin (Ng), 14-3-3, and YKL-40 proteins.Results: Biomarkers showed differences in HC subjects versus AD, FTD, and CJD. Disease groups differed between them except AD versus FTD for YKL-40. Only NF-L differed between all stages within the AD continuum. AD and FTD symptomatic mutation carriers presented differences with respect to HC subjects. Applying the AT(N) system, 96% subjects were positive for neurodegeneration if 14-3-3 was used, 94% if NF-L was used, 62% if Ng was used, and 53% if YKL-40 was used.Discussion: Biomarkers of synapse and neurodegeneration differentiate HC subjects from neurodegenerative dementias and between AD, FTD, and CJD. NF-L and 14-3-3 performed similar to total tau when AT(N) system was applied.
KW - 14-3-3
KW - AT(N) system
KW - Alzheimer's disease
KW - Biomarker
KW - Cerebrospinal fluid
KW - Creutzfeldt-Jakob disease
KW - Frontotemporal dementia
KW - MCI due to AD
KW - Mutation carriers
KW - Neu rofilament light
KW - Neurogranin
KW - Preclinical AD
KW - Ykl-40
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uab_pure&SrcAuth=WosAPI&KeyUT=WOS:000529406500002&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1016/j.jalz.2019.09.001
DO - 10.1016/j.jalz.2019.09.001
M3 - Article
C2 - 31668967
SN - 1552-5260
VL - 16
SP - 262
EP - 272
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 2
ER -